Over the course of the last decade, Anna Richo has broken new ground as legal counsel for Amgen Inc., the biopharmaceutical manufacturer with more than $15 billion in sales. When she joined Amgen in 2003 as Vice President, Law, she was the first to take on worldwide management of the company's litigation. She provided advice in several legal areas, including antitrust, product liability, and securities litigation. In 2008, Amgen created a new position for Ms. Richo, Senior Vice President & Chief Compliance Officer, in which she reported directly to the Board of Directors. More than simply ensuring regulatory compliance, Ms. Richo promotes ethical business behavior throughout the global enterprise. Previously, she served for five years on the Board of Directors of Cytyc Corporation, a maker of clinical diagnostic products for women. Anna Richo was named one of the "Top 15 Women in Pharma" by FiercePharma in 2009. In addition to her work in the pharmaceutical sector, Ms. Richo serves as a co-chair of the Straus Institute Council of Distinguished Advisors, a dispute resolution organization at Pepperdine University School of Law.
Prior to joining the biotech leader Amgen, Ms. Richo rose through the ranks of in-house counsel at Baxter Healthcare Corporation of Deerfield, Illinois. She began as Corporate Counsel in 1991 and in 1998 became Vice President, Law, for the company's $3.2 billion BioScience Division. At Baxter, in addition to her management of worldwide legal services for the company, Ms. Richo led threat management teams that responded to crises. She handled everything from corporate transactions to patent issues and regulatory compliance.
Ms. Richo attended Cornell University, where she earned a Bachelor of Science in Industrial and Labor Relations. She received her Juris Doctor in 1986 from the DePaul University College of Law in Chicago. She is admitted to the bar in Illinois and California as well as for the United States Court of Appeals for the Seventh Circuit. Anna Richo and her husband have two adult children.